Adaptive Biotechnologies (ADPT) Reports Q4 Loss, Misses Revenue Estimates

Adaptive Biotechnologies (ADPT) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to a loss of $0.23 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +52.63%. A quarter ago, it was expected that this life-sciences research company would post a loss of $0.16 per share when it actually produced a loss of $0.15, delivering a surprise of +6.25%.Over the last four ...